-
Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion.
J Virol. 2002 Apr;76(7):3522-33
PMID: 11884576
-
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.
Mol Pharmacol. 2005 Apr;67(4):1268-82
PMID: 15644495
-
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.
J Virol. 2002 Jul;76(13):6780-90
PMID: 12050391
-
HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation.
Mol Biol Cell. 2003 Mar;14(3):926-38
PMID: 12631714
-
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry.
J Virol. 2003 May;77(9):5201-8
PMID: 12692222
-
Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
J Virol. 2003 May;77(10):5829-36
PMID: 12719576
-
Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.
FEBS Lett. 2003 Jul 10;546(2-3):300-6
PMID: 12832058
-
Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists.
J Biol Chem. 2003 Nov 21;278(47):47136-44
PMID: 12958314
-
Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions.
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15812-7
PMID: 14668432
-
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor.
J Biol Chem. 2004 Jan 23;279(4):3033-41
PMID: 14585837
-
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor.
J Virol. 2004 Mar;78(6):2790-807
PMID: 14990699
-
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitors.
J Virol. 2004 Apr;78(8):4134-44
PMID: 15047829
-
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
Cell. 1986 Nov 7;47(3):333-48
PMID: 3094962
-
A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope.
AIDS Res Hum Retroviruses. 1993 Jan;9(1):23-32
PMID: 8094000
-
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.
Antimicrob Agents Chemother. 1994 Apr;38(4):668-74
PMID: 7913308
-
Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1.
J Virol. 1995 Mar;69(3):1462-72
PMID: 7853478
-
The fusion kinetics of influenza hemagglutinin expressing cells to planar bilayer membranes is affected by HA density and host cell surface.
J Gen Physiol. 1995 Nov;106(5):783-802
PMID: 8648292
-
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
J Virol. 1997 Feb;71(2):873-82
PMID: 8995603
-
Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion.
J Virol. 1997 Jul;71(7):5003-11
PMID: 9188565
-
Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry.
Science. 1997 Jun 20;276(5320):1874-8
PMID: 9188536
-
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.
J Virol. 1998 Apr;72(4):2855-64
PMID: 9525605
-
Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
J Virol. 1999 Dec;73(12):10346-58
PMID: 10559353
-
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5639-44
PMID: 10779565
-
Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins.
FEBS Lett. 2000 Jun 2;474(2-3):246-51
PMID: 10838094
-
Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1.
AIDS Res Hum Retroviruses. 2000 Jun 10;16(9):871-82
PMID: 10875613
-
Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.
J Virol. 2000 Aug;74(15):7005-15
PMID: 10888639
-
A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors.
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11215-20
PMID: 11005830
-
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.
J Cell Biol. 2000 Oct 16;151(2):413-23
PMID: 11038187
-
Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
J Biol Chem. 2001 Apr 27;276(17):14153-60
PMID: 11154697
-
HIV fusion and its inhibition.
Antiviral Res. 2001 May;50(2):95-115
PMID: 11369431
-
HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
Biochemistry. 2001 Oct 16;40(41):12231-6
PMID: 11591141
-
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo.
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12718-23
PMID: 11606733
-
Mechanisms of viral membrane fusion and its inhibition.
Annu Rev Biochem. 2001;70:777-810
PMID: 11395423
-
Capture of an early fusion-active conformation of HIV-1 gp41.
Nat Struct Biol. 1998 Apr;5(4):276-9
PMID: 9546217
-
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
Nature. 1998 Jun 18;393(6686):648-59
PMID: 9641677
-
Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100.
J Virol. 1998 Aug;72(8):6381-8
PMID: 9658078
-
CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains.
J Virol. 1999 Feb;73(2):1645-8
PMID: 9882373
-
T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure.
J Virol. 1999 Feb;73(2):1719-23
PMID: 9882387
-
Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function.
J Biol Chem. 1999 Apr 2;274(14):9617-26
PMID: 10092648
-
Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
J Virol. 1999 May;73(5):4145-55
PMID: 10196311
-
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5215-20
PMID: 10220446
-
The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.
J Virol. 2005 Jan;79(1):106-15
PMID: 15596806
-
Structure of an unliganded simian immunodeficiency virus gp120 core.
Nature. 2005 Feb 24;433(7028):834-41
PMID: 15729334
-
Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.
J Virol. 2005 Mar;79(6):3500-8
PMID: 15731244
-
Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
J Virol. 2002 Jun;76(11):5315-25
PMID: 11991960